• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益气养阴活血法治疗糖尿病肾病随机对照试验的Meta分析

A Meta-Analysis of Randomized Controlled Trials of Yiqi Yangyin Huoxue Method in Treating Diabetic Nephropathy.

作者信息

Ou Jiao Ying, Huang Di, Wu Yan Sheng, Xu Lin, He Fei, Wang Hui Ling, Shi Li Qiang, Wan Qiang, He Li Qun, Dong Gao Jian

机构信息

Department of Nephrology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, No. 528 Zhang Heng Road, Shanghai 201203, China; TCM Institute of Kidney Disease, Shanghai University of Traditional Chinese Medicine, No. 528 Zhang Heng Road, Shanghai 201203, China; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, No. 528 Zhang Heng Road, Shanghai 201203, China; Department of Internal Medicine, Shanghai TCM-Integrated Hospital of Shanghai University of Traditional Chinese Medicine, No. 184 Baoding Road, Shanghai 200082, China.

Department of Nephrology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, No. 528 Zhang Heng Road, Shanghai 201203, China; TCM Institute of Kidney Disease, Shanghai University of Traditional Chinese Medicine, No. 528 Zhang Heng Road, Shanghai 201203, China; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, No. 528 Zhang Heng Road, Shanghai 201203, China.

出版信息

Evid Based Complement Alternat Med. 2016;2016:3257603. doi: 10.1155/2016/3257603. Epub 2016 May 30.

DOI:10.1155/2016/3257603
PMID:27313643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4904113/
Abstract

Objective. The purpose of this systematic review is to evaluate the evidence of Yiqi Yangyin Huoxue Method for diabetic nephropathy. Methods. 11 electronic databases, through September 2015, were searched to identify randomized controlled trials of Yiqi Yangyin Huoxue Method for diabetic nephropathy. The quality of the included trials was assessed using the Jadad scale. Results. 26 randomized controlled trials were included in our review. Of all the included trials, most of them were considered as high quality. The aggregated results suggested that Yiqi Yangyin Huoxue Method is beneficial to diabetic nephropathy in bringing down the microalbuminuria (SMD = -0.98, 95% CI -1.22 to -0.74), serum creatinine (SMD = -0.56, 95% CI -0.93 to -0.20), beta-2 microglobulin (MD = 0.06, 95% CI 0.01 to 0.12), fasting plasma glucose (MD = -0.35, 95% CI -0.62 to -0.08), and 2-hour postprandial blood glucose (MD = 1.13, 95% CI 0.07 to 2.20), but not in decreasing blood urea nitrogen (SMD = -0.72, 95% CI -1.47 to 0.02) or 2-hour postprandial blood glucose (SMD = -0.48, 95% CI -1.01 to 0.04). Conclusions. Yiqi Yangyin Huoxue Method should be a valid complementary and alternative therapy in the management of diabetic nephropathy, especially in improving UAER, serum creatinine, fasting blood glucose, and beta-2 microglobulin. However, more studies with long follow-up are warrant to confirm the current findings.

摘要

目的。本系统评价旨在评估益气养阴活血法治疗糖尿病肾病的证据。方法。检索了截至2015年9月的11个电子数据库,以确定益气养阴活血法治疗糖尿病肾病的随机对照试验。采用Jadad量表评估纳入试验的质量。结果。我们的综述纳入了26项随机对照试验。在所有纳入的试验中,大多数被认为质量较高。汇总结果表明,益气养阴活血法有利于糖尿病肾病,可降低微量白蛋白尿(标准化均数差=-0.98,95%可信区间-1.22至-0.74)、血清肌酐(标准化均数差=-0.56,95%可信区间-0.93至-0.20)、β2微球蛋白(平均差=0.06,95%可信区间0.01至0.12)、空腹血糖(平均差=-0.35,95%可信区间-0.62至-0.08)和餐后2小时血糖(平均差=-1.13,95%可信区间0.07至2.20),但对降低血尿素氮(标准化均数差=-0.72,95%可信区间-1.47至0.02)或餐后2小时血糖(标准化均数差=-0.48,95%可信区间-1.01至0.04)无效。结论。益气养阴活血法应是糖尿病肾病管理中一种有效的补充和替代疗法,尤其是在改善尿白蛋白排泄率、血清肌酐、空腹血糖和β2微球蛋白方面。然而,需要更多长期随访的研究来证实目前的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d58f/4904113/5d810d19d0d1/ECAM2016-3257603.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d58f/4904113/edce0ece1fc7/ECAM2016-3257603.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d58f/4904113/736b25aded8c/ECAM2016-3257603.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d58f/4904113/9c166ca1938f/ECAM2016-3257603.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d58f/4904113/5d810d19d0d1/ECAM2016-3257603.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d58f/4904113/edce0ece1fc7/ECAM2016-3257603.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d58f/4904113/736b25aded8c/ECAM2016-3257603.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d58f/4904113/9c166ca1938f/ECAM2016-3257603.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d58f/4904113/5d810d19d0d1/ECAM2016-3257603.004.jpg

相似文献

1
A Meta-Analysis of Randomized Controlled Trials of Yiqi Yangyin Huoxue Method in Treating Diabetic Nephropathy.益气养阴活血法治疗糖尿病肾病随机对照试验的Meta分析
Evid Based Complement Alternat Med. 2016;2016:3257603. doi: 10.1155/2016/3257603. Epub 2016 May 30.
2
Therapeutic effects of Yiqi Huoxue prescription on diabetic nephropathy: a meta-analysis and systematic review.益气活血方治疗糖尿病肾病的疗效:Meta 分析和系统评价。
Ann Palliat Med. 2021 Jun;10(6):6617-6629. doi: 10.21037/apm-21-1147. Epub 2021 Jun 17.
3
Yiqi Yangyin Huoxue Method in Treating Diabetic Retinopathy: A Systematic Review and Meta-Analysis.益气养阴活血法治疗糖尿病视网膜病变:一项系统评价与Meta分析
Evid Based Complement Alternat Med. 2019 Apr 2;2019:6020846. doi: 10.1155/2019/6020846. eCollection 2019.
4
Effect of sitagliptin combined with Yiqi yangyin huoxue decoction on clinical efficacy and hemorheology in early diabetic nephropathy.西他列汀联合益气养阴活血汤对早期糖尿病肾病临床疗效及血液流变学的影响
World J Diabetes. 2023 Sep 15;14(9):1412-1421. doi: 10.4239/wjd.v14.i9.1412.
5
[Meta-analysis of Yiqi Huoxue method in treating idiopathic membranous nephropathy].[益气活血法治疗特发性膜性肾病的Meta分析]
Zhongguo Zhong Yao Za Zhi. 2017 Sep;42(18):3613-3622. doi: 10.19540/j.cnki.cjcmm.20170623.009.
6
The efficacy of Yiqi Huoxue therapy for chronic heart failure: A meta-analysis in accordance with PRISMA guideline.益气活血疗法治疗慢性心力衰竭的疗效:一项符合 PRISMA 指南的荟萃分析。
Medicine (Baltimore). 2022 Aug 26;101(34):e30082. doi: 10.1097/MD.0000000000030082.
7
Therapeutic effect of YiQi HuoXue BuShen decoction combined with Western medicine on hypertensive nephropathy: a meta-analysis.益气活血补肾汤联合西药治疗高血压肾病的疗效:一项Meta分析
Am J Transl Res. 2023 Jun 15;15(6):3815-3824. eCollection 2023.
8
[Clinical observation on Qidi Yiqi Yangyin Huoxue Recipe in treating diabetic nephropathy at stage III and IV].芪地益气养阴活血方治疗Ⅲ、Ⅳ期糖尿病肾病的临床观察
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Nov;26(11):1023-6.
9
Yiqi Huoxue Recipe Regulates Autophagy through Degradation of Advanced Glycation End Products via mTOR/S6K1/LC3 Pathway in Diabetic Nephropathy.益气活血方通过mTOR/S6K1/LC3途径降解晚期糖基化终产物调节糖尿病肾病中的自噬
Evid Based Complement Alternat Med. 2021 Aug 9;2021:9942678. doi: 10.1155/2021/9942678. eCollection 2021.
10
[Protective effect of Yiqi Huoxue decoction on kidney in diabetic GK rats].益气活血汤对糖尿病GK大鼠肾脏的保护作用
Zhongguo Zhong Yao Za Zhi. 2018 Jun;43(11):2372-2377. doi: 10.19540/j.cnki.cjcmm.20180327.004.

引用本文的文献

1
Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats.黄芪和三七,新型肾保护化合物,协同保护链脲佐菌素诱导的糖尿病大鼠足细胞损伤。
J Diabetes Res. 2019 Apr 16;2019:1602892. doi: 10.1155/2019/1602892. eCollection 2019.
2
Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective.糖尿病肾病的机制洞察与管理:近期进展与未来展望
J Diabetes Res. 2017;2017:1839809. doi: 10.1155/2017/1839809. Epub 2017 Mar 13.

本文引用的文献

1
Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy.黄芪治疗糖尿病肾病的临床价值的荟萃分析。
J Ethnopharmacol. 2011 Jan 27;133(2):412-9. doi: 10.1016/j.jep.2010.10.012. Epub 2010 Oct 13.
2
Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus.MCF2L2、ADIPOQ 和 SOX2 基因多态性对 1 型糖尿病肾病发生的影响。
BMC Med Genet. 2010 Jul 28;11:116. doi: 10.1186/1471-2350-11-116.
3
Microalbuminuria in patients with Type 2 diabetes mellitus from general practice: course and predictive value.
来自全科医疗的2型糖尿病患者的微量白蛋白尿:病程及预测价值。
Diabet Med. 2001 Feb;18(2):139-43. doi: 10.1046/j.1464-5491.2001.00423.x.
4
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?随机试验报告的质量会影响在荟萃分析中报告的干预效果估计值吗?
Lancet. 1998 Aug 22;352(9128):609-13. doi: 10.1016/S0140-6736(98)01085-X.
5
American Diabetes Association annual meeting, 1997, and the Teczem Consultant Meeting. Diabetic nephropathy.美国糖尿病协会1997年年会以及泰克泽姆顾问会议。糖尿病肾病。
Diabetes Care. 1998 Feb;21(2):315-9. doi: 10.2337/diacare.21.2.315.
6
Assessing the quality of reports of randomized clinical trials: is blinding necessary?评估随机临床试验报告的质量:设盲是否必要?
Control Clin Trials. 1996 Feb;17(1):1-12. doi: 10.1016/0197-2456(95)00134-4.
7
Comparative renal pathophysiology relevant to IDDM and NIDDM patients.与胰岛素依赖型糖尿病(IDDM)和非胰岛素依赖型糖尿病(NIDDM)患者相关的比较性肾脏病理生理学。
Diabetes Metab Rev. 1988 Aug;4(5):453-83. doi: 10.1002/dmr.5610040504.